Shao-Feng Duan

Shao-Feng Duan


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Cancer Letters
Verified
Journal Article
Closed access
QDQian Dong
Qian Dong
BYBo Yang
Bo Yang
JHJu-Guo Han
Ju-Guo Han
MZMeng-Meng Zhang
Meng-Meng Zhang
WLWei Liu
Wei Liu
SDShao-Feng Duan
Shao-Feng Duan

1 January 2021 in International Journal of Biological Sciences
Verified
Journal Article
Open access
ENEbenezeri Ngowi
Ebenezeri Ngowi
AAAttia Afzal
Attia Afzal
MSMuhammad Sarfraz
Muhammad Sarfraz
Saadullah KhattakSaadullah Khattak
Saadullah Khattak
SZShams Uz Zaman
Shams Uz Zaman
DWDong-Dong Wu
Dong-Dong Wu
In recent years, a vast number of potential cancer therapeutic targets have emerged. However, developing efficient and effective drugs for the targets is of major concern. Hydrogen sulfide (H2S), one of the three known gasotransmitters, is involved in the regulation of various cellular activities such as autophagy, apoptosis, migration, and proliferation. Low production of H2S has been identified in numerous cancer types. Treating cancer cells with H2S donors is the common experimental technique used to improve H2S levels; however, the outcome depends on the concentration/dose, time, cell type, and sometimes the drug used. Both natural and synthesized donors are available for this purpose, although their effects vary independently ranging from strong cancer suppressors to promoters. Nonetheless, numerous signaling pathways have been reported to be altered following the treatments with H2S donors which suggest their potential in cancer treatment. This review will analyze the potential of H2S donors in cancer therapy by summarizing key cellular processes and mechanisms involved.

19 November 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ENEbenezeri Ngowi
Ebenezeri Ngowi
MSMuhammad Sarfraz
Muhammad Sarfraz
AAAttia Afzal
Attia Afzal
NKNazeer Hussain Khan
Nazeer Hussain Khan
Saadullah KhattakSaadullah Khattak
Saadullah Khattak
DWDong-Dong Wu
Dong-Dong Wu
Hydrogen sulfide (H2S) plays a key role in the regulation of physiological processes in mammals. The decline in H2S level has been reported in numerous renal disorders. In animal models of renal disorders, treatment with H2S donors could restore H2S levels and improve renal functions. H2S donors suppress renal dysfunction by regulating autophagy, apoptosis, oxidative stress, and inflammation through multiple signaling pathways, such as TRL4/NLRP3, AMP-activated protein kinase/mammalian target of rapamycin, transforming growth factor-β1/Smad3, extracellular signal-regulated protein kinases 1/2, mitogen-activated protein kinase, and nuclear factor kappa B. In this review, we summarize recent developments in the effects of H2S donors on the treatment of common renal diseases, including acute/chronic kidney disease, renal fibrosis, unilateral ureteral obstruction, glomerulosclerosis, diabetic nephropathy, hyperhomocysteinemia, drug-induced nephrotoxicity, metal-induced nephrotoxicity, and urolithiasis. Novel H2S donors can be designed and applied in the treatment of common renal diseases.

14 March 2019 in Oncogenesis
Verified
Journal Article
Open access
PDF file
DWDa-Yong Wang
Da-Yong Wang
YHYa Hong
Ya Hong
YCYa-Ge Chen
Ya-Ge Chen
PDPeng-Zhen Dong
Peng-Zhen Dong
SLShi-Yu Liu
Shi-Yu Liu
XJXin-Ying Ji
Xin-Ying Ji
Lung cancer is the leading cause of cancer-related mortality worldwide. PEST-containing nuclear protein (PCNP) has been found in the nucleus of cancer cells. Whether PCNP plays a role in the growth of lung adenocarcinoma is still unknown. In the present study, the results indicated that the level of PCNP in lung adenocarcinoma tissue was significantly higher than that in corresponding adjacent non-tumor tissue. Over-expression of PCNP promoted the proliferation, migration, and invasion of lung adenocarcinoma cells, while down-regulation of PCNP exhibited opposite effects. PCNP over-expression decreased apoptosis through up-regulating the expression levels of phospho (p)-signal transducers and activators of transcription (STAT) 3 and p-STAT5 in lung adenocarcinoma cells, whereas PCNP knockdown showed opposite trends. PCNP overexpression enhanced autophagy by increasing the expression levels of p-phosphatidylinositol 3-kinase (PI3K), p-Akt, and p-mammalian target of rapamycin (mTOR) in lung adenocarcinoma cells, however an opposite trend was observed in the sh-PCNP group. In addition, overexpression of PCNP showed the tumor-promoting effect on xenografted lung adenocarcinoma, while PCNP knockdown reduced the growth of lung adenocarcinoma via regulating angiogenesis. Our study elucidates that PCNP can regulate the procession of human lung adenocarcinoma cells via STAT3/5 and PI3K/Akt/mTOR signaling pathways. PCNP may be considered as a promising biomarker for the diagnosis and prognosis in patients with lung adenocarcinoma. Furthermore, PCNP can be a novel therapeutic target and potent PCNP inhibitors can be designed and developed in the treatment of lung adenocarcinoma.

13 January 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
DWDong-Dong Wu
Dong-Dong Wu
SLShi‐Yu Liu
Shi‐Yu Liu
YGYing‐Ran Gao
Ying‐Ran Gao
DLDan Lu
Dan Lu
YHYa Hong
Ya Hong
XJXin-Ying Ji
Xin-Ying Ji
Tumour necrosis factor‐α‐induced protein 8‐like 2 (TIPE2) is a tumour suppressor in many types of cancer. However, the mechanism of action of TIPE2 on the growth of rectal adenocarcinoma is unknown. Our results showed that the expression levels of TIPE2 in human rectal adenocarcinoma tissues were higher than those in adjacent non‐tumour tissues. Overexpression of TIPE2 reduced the proliferation, migration, and invasion of human rectal adenocarcinoma cells and down‐regulation of TIPE2 showed reverse effects. TIPE2 overexpression increased apoptosis through down‐regulating the expression levels of Wnt3a, phospho (p)‐β‐Catenin, and p‐glycogen synthase kinase‐3β in rectal adenocarcinoma cells, however, TIPE2 knockdown exhibited reverse trends. TIPE2 overexpression decreased autophagy by reducing the expression levels of p‐Smad2, p‐Smad3, and transforming growth factor‐beta (TGF‐β) in rectal adenocarcinoma cells, however, TIPE2 knockdown showed opposite effects. Furthermore, TIPE2 overexpression reduced the growth of xenografted human rectal adenocarcinoma, whereas TIPE2 knockdown promoted the growth of rectal adenocarcinoma tumours by modulating angiogenesis. In conclusion, TIPE2 could regulate the proliferation, migration, and invasion of human rectal adenocarcinoma cells through Wnt/β‐Catenin and TGF‐β/Smad2/3 signalling pathways. TIPE2 is a potential therapeutic target for the treatment of rectal adenocarcinoma.

25 August 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MSMuhammad Sarfraz
Muhammad Sarfraz
AAAttia Afzal
Attia Afzal
Saadullah KhattakSaadullah Khattak
Saadullah Khattak
USUmair A. K. Saddozai
Umair A. K. Saddozai
HLHui‐Min Li
Hui‐Min Li
XJXin-Ying Ji
Xin-Ying Ji